EP. 4: Case 1: Outcomes in Chemotherapy-Treated Patients With DLBCLByTargeted OncologyOctober 28th 2020
EP. 5: Case 1: Therapy for Relapsed DLBCL in Transplant-Eligible PatientsByTargeted OncologyOctober 28th 2020
EP. 6: Case 1: Trials in CAR T-Cell for Patients With Relapsed/Refractory DLBCLByTargeted OncologyOctober 28th 2020
EP. 7: Case 1: Therapeutic Options After CAR T-Cell in Relapsed/Refractory DLBCLByTargeted OncologyOctober 28th 2020
EP. 9: Case 2: Therapeutic Options in Patients With Transplant-Ineligible, Treatment-Refractory DLBCLByTargeted OncologyOctober 28th 2020
EP. 10: Case 2: Considerations for Choosing a Second-Line Therapy for DLBCLByTargeted OncologyOctober 28th 2020
EP. 11: Case 2: Phase 2 L-MIND Clinical Trial for Relapsed/Refractory DLBCLByTargeted OncologyOctober 28th 2020
EP. 12: Case 2: Role of L-MIND Regimen as Second-Line Treatment in Transplant Ineligible DLBCL ByTargeted OncologyOctober 28th 2020
